Technology 23 May 2026 - 26 May 2026

NeuroSense trades close to 90 cents as next $1 Nasdaq threshold comes into view
····

NeuroSense trades close to 90 cents as next $1 Nasdaq threshold comes into view

NeuroSense Therapeutics shares rose 5 cents to 87 cents Tuesday, staying below Nasdaq’s $1 minimum bid price. The company faces delisting risk, needing its stock to close above $1 and its market value to reach $35 million for 10 days by Sept. 29, 2026. NeuroSense recently raised $600,000 in a private share sale. Its ALS drug candidate, PrimeC, is set for Phase 3 trials after FDA clearance.
May 26, 2026
Intuit QuickBooks Index flags small-business job losses as U.S. payrolls report nears
····

Intuit Drops Again With TurboTax AI Questions Back in Focus

Intuit shares fell 3.8% to $307.93 midday Tuesday, underperforming tech peers after Mizuho cut its price target to $500 from $600. The drop followed weak TurboTax results, rising AI competition, and news of a 17% staff cut. Intuit raised its full-year revenue forecast but lowered its TurboTax outlook. The company expects up to $340 million in restructuring charges.
May 26, 2026
Stagwell Jumps After Holiday, AI Push in Focus
····

Stagwell Jumps After Holiday, AI Push in Focus

Stagwell shares rose 3.4% to $6.73 midday Tuesday, outpacing the broader market after the Memorial Day break. The company last reported Q1 revenue up 8% to $704 million but posted a larger GAAP net loss. Management reaffirmed its 2026 outlook and continued buybacks, purchasing 7.3 million shares in Q1. Trading volume reached about 660,000 shares.
May 26, 2026
Quantumsphere Shares Flat After Holiday Reopen With $300 Million SPAC Deal Ahead
······

Quantumsphere Shares Flat After Holiday Reopen With $300 Million SPAC Deal Ahead

Quantumsphere Acquisition Corp. shares showed zero volume by midday Tuesday, quoted at $10.19 on Robinhood. QUMSU units last traded flat at $10.34. The $300 million SACH merger remains pending, awaiting approvals and minimum cash after redemptions. Nasdaq rose over 1% as tech stocks rallied, but Quantumsphere shares did not move.
May 26, 2026
Amkor Shares Rise in Early Trade on AI Chip-Packaging Demand
····

Amkor Shares Rise in Early Trade on AI Chip-Packaging Demand

Amkor Technology shares jumped 8.68% to $71.46 in premarket trading Tuesday, following strong Q1 results and new details on its advanced packaging work with AMD. The company set 2028 revenue targets near $9 billion and aims for $5 EPS, according to an SEC filing. Amkor recently acquired more land for its Arizona project but cautioned about construction risks. U.S. markets reopened after Memorial Day.
May 26, 2026
Ensysce Faces New Nasdaq Issue as Deadline Nears
····

Ensysce Faces New Nasdaq Issue as Deadline Nears

Ensysce Biosciences shares fell in pre-market trading after the company disclosed a Nasdaq warning over possible delisting due to a stockholders’ equity deficit. Ensysce reported negative equity of $669,012 as of March 31, down from $2.9 million at year-end. The company has until July 6 to submit a compliance plan and is also under pressure to lift its share price above $1. ENSC last traded near $0.31 early Tuesday.
May 26, 2026
Lesaka Technologies Shares Flat as Firm Eyes Profit Amid Merchant Focus
·····

Lesaka Technologies Shares Flat as Firm Eyes Profit Amid Merchant Focus

Lesaka Technologies’ JSE shares traded flat at 8,101 cents Tuesday, with just 255 shares changing hands by midday. The company recently corrected its headline earnings per share to $0.03 for the third quarter, with headline earnings at $2.171 million. Nasdaq-listed shares last closed at $4.94 before the U.S. Memorial Day holiday. Merchant segment revenue fell 13% in rand terms for the third quarter.
May 26, 2026
Comcast shares flat near lows with Tuesday’s reopen ahead
····

Comcast shares flat near lows with Tuesday’s reopen ahead

Comcast shares closed Friday at $25.20, near a 52-week low of $24.12, despite the S&P 500 and Dow hitting records. The company reported a 5.3% revenue rise but net income fell 35.6%, with adjusted EPS down 27.5% to 79 cents. Peacock subscribers rose to 46 million, but streaming losses widened to $432 million. Broadband and video subscriber declines continue to pressure results.
May 25, 2026
Hitek Global Holds Close to 52-Week Low After Holiday
····

Hitek Global Holds Close to 52-Week Low After Holiday

Hitek Global Inc. shares closed Friday at $0.6700, up 0.72%, but slipped to $0.6601 after hours, trading near a 52-week low. The Nasdaq is closed Monday for Memorial Day, with regular trading to resume Tuesday. HKIT dropped about 2.5% last week and remains in micro-cap territory with a market cap near $6.47 million. Revenue for fiscal 2025 rose to $6.5 million, but gross profit and cash declined.
May 25, 2026
Ambarella Up 8% This Week With AI Earnings On Deck
····

Ambarella Up 8% This Week With AI Earnings On Deck

Ambarella shares rose 4.67% Friday to $87.55 ahead of fiscal Q1 results due after the bell Thursday. The stock gained 7.9% last week, outperforming the Philadelphia Semiconductor Index. Nasdaq will close Monday for Memorial Day, with regular trading resuming Tuesday. Analysts maintain a Buy consensus, but Ambarella’s heavy reliance on WT Microelectronics and competition from Mobileye and Nvidia remain risks.
May 25, 2026
Cyngn Shares Eye $1.43 Level as Deployments Go Up, Losses Persist
····

Cyngn Shares Eye $1.43 Level as Deployments Go Up, Losses Persist

Cyngn Inc. shares closed at $1.43 Friday, unchanged for the week and near a 52-week low, ahead of the Memorial Day market closure. First-quarter revenue rose to $104,573 from $47,152 a year earlier, while net loss widened to $6.49 million. Trading volume Friday was about 175,450 shares, below average. The stock recovered from a midweek low of $1.29 but remains thinly traded.
May 24, 2026
IZEA Stock’s Buyback Window Opens After a Revenue Reset. Here’s What Traders Watch Next
····

IZEA Stock’s Buyback Window Opens After a Revenue Reset. Here’s What Traders Watch Next

Quantum Computing Inc. (QUBT) jumped 7.89% to close at $12.31 Friday, with volume at 67.5 million shares, after the U.S. Commerce Department announced $2.013 billion in quantum funding that excluded QUBT. IBM, GlobalFoundries, D-Wave, and Rigetti were named as award recipients. Nasdaq is closed Monday for Memorial Day; trading resumes Tuesday.
May 24, 2026
All eyes on Autodesk ahead of earnings
····

All eyes on Autodesk ahead of earnings

Autodesk shares closed Friday at $240.99, up 0.33% for the day and 1.9% for the week. U.S. markets are closed for Memorial Day on Monday, leaving three trading days before Autodesk reports fiscal Q1 earnings after the close on May 28. The company has forecast revenue of $1.885–$1.900 billion and non-GAAP EPS of $2.82–$2.86.
May 23, 2026
Rambus Stock Rises Heading Into Memorial Day as AI Memory Stocks Wait for Next Move
····

Rambus Stock Rises Heading Into Memorial Day as AI Memory Stocks Wait for Next Move

Rambus Inc. shares jumped 12.5% to close at $142.98 Friday, outperforming the Nasdaq and PHLX semiconductor index ahead of the Memorial Day market closure. The stock rebounded midweek after early declines, gaining over 9% Wednesday and 6% Thursday. Rambus recently reported Q1 revenue of $180.2 million and raised its AI infrastructure profile with new PCIe 7.0 switch IP. A May 22 Form 144 filing signaled a planned insider share sale.
May 23, 2026
1 2 3 4 5 … 123

Stock Market Today

  • Bell Potter Sees Potential 100%+ Gain in Imugene ASX Healthcare Stock
    May 28, 2026, 7:13 PM EDT. Imugene Ltd (ASX: IMU) shares surged after Bell Potter highlighted progress in its Phase 1b trial targeting rare Non-Hodgkin's Lymphoma (NHL). The trial tests azer-cel combined with BTKi drugs, aiming to improve treatment for patients resistant to previous therapies. Bell Potter is optimistic, citing high response rates in related studies and the advantage of the off-the-shelf availability of azer-cel. The broker expects rapid enrolment and early data within weeks, reaffirming a speculative buy rating with a 25 cent price target, over double the current share price. Imugene addresses a critical unmet medical need, positioning it as a notable ASX healthcare stock with significant upside potential.